chlorpromazine has been researched along with Mouth Neoplasms in 3 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
Mouth Neoplasms: Tumors or cancer of the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, treatment of human oral cancer cells with CPZ inhibited their proliferation and induced G2/M phase arrest." | 1.62 | Chlorpromazine, an antipsychotic agent, induces G2/M phase arrest and apoptosis via regulation of the PI3K/AKT/mTOR-mediated autophagy pathways in human oral cancer. ( Chang, HC; Han, KF; Hung, CC; Jhou, AJ; Lai, YW; Lee, CH; Lee, YC; Lin, HC; Lin, MY; Liu, WT, 2021) |
| "A 57-year-old schizoaffective disorder patient was placed on chlorpromazine because of its sedative properties and low profile for extrapyramidal side effects." | 1.29 | Cutaneous and ocular changes associated with the use of chlorpromazine. ( Berk, MA; Mosnaim, AD; Richer, S; Wolf, ME, 1993) |
| "Twenty-nine patients with advanced mouth cancer have completed a course of this treatment, of whom five of nine were free of disease after 2 years and 10 of 21 at 1 year, with three intercurrent deaths." | 1.27 | A feasibility study of a new approach to clinical radiosensitisation: hypothermia and hyperbaric oxygen in combination with pharmacological vasodilatation. ( Barry, L; Blekkenhorst, G; Boniaszczuk, J; Fataar, AB; Gregory, A; Harrison, GG; Hering, ER; Korrubel, J; Morrell, D; Sealy, R, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jhou, AJ | 1 |
| Chang, HC | 1 |
| Hung, CC | 1 |
| Lin, HC | 1 |
| Lee, YC | 1 |
| Liu, WT | 1 |
| Han, KF | 1 |
| Lai, YW | 1 |
| Lin, MY | 1 |
| Lee, CH | 1 |
| Wolf, ME | 1 |
| Richer, S | 1 |
| Berk, MA | 1 |
| Mosnaim, AD | 1 |
| Sealy, R | 1 |
| Harrison, GG | 1 |
| Morrell, D | 1 |
| Korrubel, J | 1 |
| Gregory, A | 1 |
| Barry, L | 1 |
| Blekkenhorst, G | 1 |
| Hering, ER | 1 |
| Fataar, AB | 1 |
| Boniaszczuk, J | 1 |
3 other studies available for chlorpromazine and Mouth Neoplasms
| Article | Year |
|---|---|
Chlorpromazine, an antipsychotic agent, induces G2/M phase arrest and apoptosis via regulation of the PI3K/AKT/mTOR-mediated autophagy pathways in human oral cancer.
Topics: Animals; Antineoplastic Agents; Antipsychotic Agents; Autophagy; Cell Line, Tumor; Chlorpromazine; E | 2021 |
Cutaneous and ocular changes associated with the use of chlorpromazine.
Topics: Carcinoma, Basal Cell; Chlorpromazine; Drug Eruptions; Eye Diseases; Humans; Male; Middle Aged; Mout | 1993 |
A feasibility study of a new approach to clinical radiosensitisation: hypothermia and hyperbaric oxygen in combination with pharmacological vasodilatation.
Topics: Anesthesia, Intravenous; Carcinoma, Squamous Cell; Chlorpromazine; Feasibility Studies; Humans; Hype | 1986 |